STALICLA
PrivateLast Round
VC Round
Jun 30, 2025
Total Funding Raised
$49.86M
Company Overview
STALICLA is a biopharmaceutical company that develops precision medicine for neurodevelopmental and neuropsychiatric disorders using its proprietary DEPI platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
STALICLA Comparables
Compare STALICLA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alto Neuroscience | 77% | |
| Itay & Beyond | 76% | |
| Insilico Medicine | 76% |
STALICLA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 30, 2025 | ||||
| Series B | Jan 16, 2024 | ||||
| Series A | Feb 3, 2020 | ||||
| Seed | Jun 30, 2018 |
Key People
Founding team and executive leadership
STALICLA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 4see ventures | Series A |
| Akilia Partners | Seed, Series B, Series A |
| SPRIM Global Investments | Series B |
| Forestay Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 52% MoM.
- Feb 7, 2026
Grew 19% QoQ, from 21 to 25 employees.
STALICLA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about STALICLA's valuation, stock price, and market status.
Is STALICLA a public or private company?
STALICLA is a private company.
What is the current stock price of STALICLA?
STALICLA is a private company, so its shares have no public market price. Caplight tracks STALICLA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is STALICLA worth (valuation)?
Valuation information for STALICLA is not publicly available.
Can I buy STALICLA stock?
STALICLA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was STALICLA's last funding round?
STALICLA's most recent funding round was VC Round on June 30, 2025.
Who are the main investors in STALICLA?
Key investors in STALICLA include SPRIM Global Investments.
Will STALICLA IPO soon?
No public IPO plans have been announced for STALICLA.
How can I track STALICLA secondary market activity?
Caplight tracks bids, offers, and trades in STALICLA's shares on secondary markets.